Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies
GeekWire
SEPTEMBER 19, 2023
Colleen Delaney, the founder, chief scientific officer, and executive vice president of research and development at Deverra Therapeutics. Founded in 2019, Deverra has an exclusive license from Fred Hutchinson Cancer Research Center for a stem cell expansion and directed-differentiation platform.
Let's personalize your content